Des-gamma-carboxy prothrombin (DCP) as a biomarker for treatment response in hepatocellular carcinoma.

被引：1
|
作者：
Conner, Elizabeth
Chang, Jeremy
Burgoyne, Adam
机构：
[1] Univ Calif San Diego, San Diego, CA USA
[2] Univ Calif San Diego, La Jolla, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
283-424-425; 613-3267-9109-8855-5546; 130-540-543-4790; 613-135-2370-5109; 298-145-222-184-4809; 5; 4; 3; 2; 1854; 182; 7; 6;
D O I：
10.1200/JCO.2024.42.3_suppl.547
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：547 / 547
页数：1
相关论文
共 50 条
  • [31] CLINICAL USEFULNESS OF DES-GAMMA-CARBOXY PROTHROMBIN ASSAY IN EARLY DIAGNOSIS OF HEPATOCELLULAR-CARCINOMA
    FUJIYAMA, S
    IZUNO, K
    GOHSHI, K
    SHIBATA, J
    SATO, T
    DIGESTIVE DISEASES AND SCIENCES, 1991, 36 (12) : 1787 - 1792
  • [32] Usefulness of simultaneous determination of alpha-fetoprotein and des-gamma-carboxy prothrombin in hepatocellular carcinoma
    Nakao, A
    Taniguchi, K
    Inoue, S
    Harada, A
    Nonami, T
    Watanabe, K
    Takagi, H
    SEMINARS IN SURGICAL ONCOLOGY, 1996, 12 (03): : 160 - 163
  • [33] Diagnostic accuracy of des-gamma-carboxy prothrombin versus α-fetoprotein for hepatocellular carcinoma: A systematic review
    Li, Changzai
    Zhang, Zhiming
    Zhang, Pan
    Liu, Jianyong
    HEPATOLOGY RESEARCH, 2014, 44 (10) : E11 - E25
  • [34] Increase of serum des-gamma-carboxy prothrombin in alcoholic liver disease without hepatocellular carcinoma
    Ohhira, M
    Ohtake, T
    Saito, H
    Ikuta, K
    Tanaka, K
    Tanabe, H
    Kawashima, T
    Fujimoto, Y
    Naraki, T
    Ono, M
    Kohgo, Y
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1999, 23 (04) : 67S - 70S
  • [35] The Impact of des-gamma-Carboxy Prothrombin on Outcome of Living Donor Liver Transplantation for Hepatocellular Carcinoma
    Fujiki, Masato
    Takada, Yasutsugu
    Uemoto, Shinji
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 442 - 442
  • [36] DES-GAMMA-CARBOXY PROTHROMBIN IN TISSUES OF HEPATOCELLULAR-CARCINOMA - IMMUNOHISTOCHEMICAL AND IMMUNOELECTRON MICROSCOPIC STUDIES
    FUKUSATO, T
    MACHINAMI, R
    TOMIMATSU, M
    OKUDA, H
    OBATA, H
    OHKUBO, A
    HEPATOLOGY, 1990, 12 (02) : 404 - 404
  • [37] Doubling Time of Des-gamma-carboxy Prothrombin Can be Useful as a Prognostic Marker for Hepatocellular Carcinoma
    Matsumoto, Nobuyuki
    Ikeda, Hiroki
    Noguchi, Yohei
    Shigefuku, Ryuta
    Matsunaga, Kotaro
    Okuse, Chiaki
    Suzuki, Michihiro
    Itoh, Fumio
    HEPATOLOGY, 2014, 60 : 863A - 863A
  • [38] DES-GAMMA-CARBOXY (ABNORMAL) PROTHROMBIN - A NEW SERUM MARKER OF PRIMARY HEPATOCELLULAR-CARCINOMA
    LIEBMAN, HA
    FURIE, BC
    BLANCHARD, RA
    TONG, MJ
    LO, KJ
    LEE, SD
    FURIE, B
    CLINICAL RESEARCH, 1983, 31 (02): : A476 - A476
  • [39] CHANGES OF PLASMA DES-GAMMA-CARBOXY PROTHROMBIN LEVELS IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA IN RESPONSE TO VITAMIN-K
    FURUKAWA, M
    NAKANISHI, T
    OKUDA, H
    ISHIDA, S
    OBATA, H
    CANCER, 1992, 69 (01) : 31 - 38
  • [40] POSTABLATION DES-GAMMA-CARBOXY PROTHROMBIN: PREDICTION OF PROGNOSIS IN HEPATITIS B-RELATED HEPATOCELLULAR CARCINOMA
    Lee, S.
    Rhim, H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S342 - S342
12345